Onco Cell Therapy Summit

Onco Cell Therapy Summit

Reagan Jarvis, our CEO is speaking at this summit. He’ll be talking about our integrated target discovery and TCR generation pipelines for accessing broad target spaces and developing TCR-modified cell therapies. Reach out if you would like to connect.
TCR-based Therapies for Solid Tumours Summit

TCR-based Therapies for Solid Tumours Summit

Our CEO, Reagan Jarvis, is in Boston for this conference. Reagan is speaking about our standardised cellular assay platforms for the systematic characterisation of off-Target TCR toxicities. Get in touch with us if you would like to connect.

Anocca: Standardizing TCR cell therapy design

Originally published in BioCentury. Anocca is using engineered human cells to recapitulate the T cell immune system ex vivo, eliminating the person-to-person variability in working with primary T cells from patients, to create standardized, scalable TCR-modified T...